{"version":"1.0","type":"link","title":"Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal Cancer.","author_name":"Keyl J 외","author_url":"https://prs-insight.online/author/Keyl%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/104663","thumbnail_width":1200,"thumbnail_height":630}